Tag: pubmed

Sci Total Environ. 2021 Aug 21;802:149721. doi: 10.1016/j.scitotenv.2021.149721. Online ahead of print.

ABSTRACT

The natural flow regime (i.e. magnitude, frequency, duration, timing and rate of change of flow events) is crucial for maintaining freshwater biodiversity and ecosystem services. Protecting instream flow from anthropogenic alterations first requires an understanding of the relationship between aquatic organisms and the flow regime. In this study, we used a unique framework based on random forest modeling to quantify effects of natural flow regime metrics on fish and macroinvertebrate assemblages across ecoregions and flow regime types in the state of South Carolina, USA. We found that all components of the natural flow regime affected both fish and benthic macroinvertebrate assemblages, suggesting that maintaining natural aspects of all flow regime components is critical for protecting freshwater diversity. We identified hydrologic metrics and flow regime components such as magnitude, frequency, and duration of flow events, that were associated with the greatest ecological responses for individual stream classes to help managers prioritize hydrologic and biological metrics of interest during environmental flow standard development. The response of aquatic organisms to hydrologic metrics varied across stream classifications and ecoregions, highlighting the importance of accounting for differences in flow regime and ecoregion when designing environmental flow standards. We provide a flexible framework based on statistical flow-ecology relationships that can be used to inform instream flow management and assess effects of flow alteration on riverine assemblages.

PMID:34454154 | DOI:10.1016/j.scitotenv.2021.149721

J Esthet Restor Dent. 2021 Aug 28. doi: 10.1111/jerd.12814. Online ahead of print.

ABSTRACT

OBJECTIVE: To compare at-home systems with reduced daily time of use (10% hydrogen peroxide [HP] gel with prefilled (PT) or customized trays (CT), and 10% carbamide peroxide [CP] gel), with the conventional nightguard vital bleaching (10% CP). Bleaching efficacy, adverse effects, and patient’s satisfaction were evaluated.

METHODS: Sixty participants were randomly divided into treatments (14 days): Opalescence GO (OGO)-10%HP PT-30 min, White Class-10%HP CT-30 min, Opalescence PF-10%CP CT-2 h, and Opalescence PF-10%CP CT-8 h. Color difference (visual and spectrophotometer), tooth sensitivity (visual analogue scale), gingival condition (Löe index), enamel mineralization (laser fluorescence), and patients’ satisfaction (questionnaire) were assessed. Statistical tests were applied (5%).

RESULTS: After 1 year, color difference was similar for the groups (p > 0.05). All groups showed similar sensitivity risk (p > 0.05). The intensity of sensitivity and gingival irritation was mild for all gels, but higher for OGO. Fluorescence after bleaching remained similar to those of sound enamel. All participants were satisfied with treatments.

CONCLUSIONS: All systems produced similar bleaching efficacy, which was maintained after 1 year. Patients were satisfied with bleaching outcomes. Tooth sensitivity occurred in all groups, but with overall mild intensity. No relevant gingival irritation and enamel demineralization was observed.

CLINICAL SIGNIFICANCE: Bleaching with 10% HP gels in prefilled and CTs represent efficacious alternative for tooth color change, with patients’ acceptance similar to conventional 10% CP. Patients must be warned about the mild sensitivity and gingival irritation potential, mainly with PTs.

PMID:34453873 | DOI:10.1111/jerd.12814

J Appl Clin Med Phys. 2021 Aug 28. doi: 10.1002/acm2.13405. Online ahead of print.

ABSTRACT

PURPOSE: This paper proposes a model for the angular dependency of MatriXX response and investigates whether MatriXX, with the angular-model-based approach can be applied to true composite dose verification for IMRT plans.

METHOD: This model attributes the angular dependence of MatriXX response to dynamical translation of its effective measurement plane (EMP) due to the change of beam angle. Considering this mechanism, true composite dose verifications for IMRT plans specified in AAPM TG 119 report using both MatriXX and Gafchromic EBT3 films were undertook and compared to validate the applicability of MatriXX for patient specific QA of composite beam IMRT plans. Dose verifications using MatriXX with and without angular-model-based approach were performed.

RESULTS: MatriXX with angular-model-based approach achieved gamma passing rates with 3%/3 mm and 3%/2 mm criteria better than 98.3% and 98.1% respectively for true composite dose verification of plans in AAPM TG 119 report. The 3%/3 mm and 3%/2 mm gamma passing rates using MatriXX without angular-model-based approach ranged from 85.8% to 98.2% and from 81.3% to 96.5%, respectively. The p-values from the single sided paired t-test indicated no statistical difference between the passing rates from MatriXX with angular-model-based approach and from films, and significant difference between the passing rates from uncorrected MatriXX and from films.

CONCLUSION: The proposed model for angular dependent MatriXX response is necessary and effective. Dose verification using MatriXX with angular-model-based approach is acceptable for true composite beam IMRT plans with required accuracy to simplify patient specific QA.

PMID:34453876 | DOI:10.1002/acm2.13405

Pediatr Allergy Immunol. 2021 Aug 28. doi: 10.1111/pai.13656. Online ahead of print.

ABSTRACT

BACKGROUND: The Global Asthma Network (GAN), by using the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, has updated trends in prevalence of symptoms of childhood allergic diseases, including non-infective rhinitis and conjunctivitis (“rhinoconjunctivitis”) which is reported here.

METHODS: Prevalence and severity of rhinoconjunctivitis were assessed by questionnaire among schoolchildren in GAN Phase I and ISAAC Phases I and III surveys 15-23 years apart. Absolute rates of change in prevalence were estimated for each centre and modelled by multi-level linear regression to compare trends by age group, time period and per-capita national income.

RESULTS: 27 GAN centres in 14 countries surveyed 74,361 13-14-year-olds (“adolescents”) and 45,434 6-7-year-olds (“children”), with average response proportions of 90% and 79% respectively. Many centres showed highly significant (p<0.001) changes in prevalence of rhinoconjunctivitis in the past year (“current rhinoconjunctivitis”), compared to ISAAC. The direction and magnitude of centre-level trends varied significantly (p<0.001) both within and between countries. Overall, current rhinoconjunctivitis prevalence decreased slightly from ISAAC Phase III to GAN: -1.32% per 10 years, 95%CI [-2.93%, +0.30%] among adolescents; -0.44% [-1.29%, +0.42%] among children. Together, these differed significantly (p<0.001) from the upward trend within ISAAC. Among adolescents, centre-level trends in current rhinoconjunctivitis were highly correlated with those for eczema symptoms (rho=0.72, p<0.0001) but not with centre-level trends in asthma symptoms (rho=0.15, p=0.48). Among children, these correlations were positive but not significant.

CONCLUSION: Symptoms of non-infective rhinoconjunctivitis among schoolchildren may no longer be on the increase globally, although trends vary substantially within and between countries.

PMID:34453861 | DOI:10.1111/pai.13656

Electrophoresis. 2021 Aug 28. doi: 10.1002/elps.202100211. Online ahead of print.

ABSTRACT

Proteomic characterization of alveolar bones in oral surgery represents an analytical challenge due to their insoluble character. The implementation of a straightforward technique could lead to the routine use of proteomics in this field. We have thus developed a simple technique for the characterization of bone tissue for human maxillary and mandibular bones. It is based on the direct in-bone tryptic digestion of proteins in both healthy and pathological human maxillary and mandibular bone samples. The released peptides were then identified by the LC-MS/MS. Using this approach, a total of 1120 proteins were identified in the maxillary bone and 1151 proteins in the mandibular bone. The subsequent partial least squares – discrimination analysis of protein data made it possible to reach 100% discrimination between the samples of healthy alveolar bones and those of the bone tissue surrounding the inflammatory focus. These results indicate that the in-bone protein digestion followed by the LC-MS/MS and subsequent statistical analysis can provide a deeper insight into the field of oral surgery at the molecular level. Furthermore, it could also have a diagnostic potential in the differentiation between the proteomic patterns of healthy and pathological alveolar bone tissue. Data are available via ProteomeXchange with the identifier PXD026775. This article is protected by copyright. All rights reserved.

PMID:34453862 | DOI:10.1002/elps.202100211

Eur Heart J Acute Cardiovasc Care. 2021 Aug 28:zuab072. doi: 10.1093/ehjacc/zuab072. Online ahead of print.

ABSTRACT

Risk stratification dates to the dawn of the cardiac intensive care unit (CICU). As the CICU has evolved from a dedicated unit caring for patients with acute myocardial infarction to a complex healthcare environment encompassing a broad array of acute and chronic cardiovascular pathology, an expanding array of risk scores are available that can be applied to CICU patients. Most of these scores were designed for use either in patients with a specific acute cardiovascular diagnosis or unselected critically ill patients, and risk scores developed in other populations often underperform in the CICU. More recently, risk scores have been developed specific to the CICU population, demonstrating improved performance. All existing risk scores have relevant limitations, both in terms of performance and applicability to patient care. Risk scores have been predominantly developed to predict short-term mortality, either by quantifying severity of illness or by incorporating other risk factors for mortality. It is essential to distinguish mortality risk attributable to severity of illness, which may be modifiable through intervention, from mortality risk attributable to non-modifiable risk factors. This review discusses established risk scores applicable to the CICU population, details how risk score performance is characterized, describes how new risk scores can be developed, explains how the information provided by risk scores can be used in clinical practice, and highlights how novel risk stratification approaches can be developed.

PMID:34453848 | DOI:10.1093/ehjacc/zuab072

Aliment Pharmacol Ther. 2021 Aug 28. doi: 10.1111/apt.16580. Online ahead of print.

ABSTRACT

BACKGROUND: Increase in lipid levels associated with the treatment of inflammatory bowel disease (IBD) has previously been reported. However, it is unknown if this effect is similar for all IBD drug classes.

AIM: To precisely assess the effect of different IBD drug classes on lipid profiles METHODS: We performed a systematic literature search of randomised controlled trials and observational cohort studies that assessed lipid levels before and after induction (≤10 weeks) and maintenance (>10 weeks) of IBD treatment. Data of 11 studies (1663 patients) were pooled using random effects models. The influence of patient and disease characteristics on treatment effects on total cholesterol levels was analysed in 6 studies (1211 patients) for which individual data were available, using linear mixed models.

RESULTS: A statistically significant increase in total cholesterol was observed after induction treatment with corticosteroids (+1.19 mmol/L, 95% confidence interval [CI₉₅ ] +0.52 to +2.59), and tofacitinib (+0.66 mmol/L, CI₉₅ +0.42 to +0.79), but not after anti-TNFα treatment (-0.11 mmol/L, CI₉₅ -0.26 to +0.36 mmol/L). Similar differences were observed after maintenance treatment. Treatment effects were significantly related to age, but not with other factors. Lipid changes were inversely correlated with but not modified by CRP changes.

CONCLUSIONS: Increase in total cholesterol levels was strongest for corticosteroids followed by tofacitinib but was not observed for anti-TNFα agents. Whether total cholesterol change associated with IBD treatment has an effect on cardiovascular risk requires further study.

PMID:34453860 | DOI:10.1111/apt.16580

J Natl Cancer Inst. 2021 Aug 28:djab174. doi: 10.1093/jnci/djab174. Online ahead of print.

ABSTRACT

BACKGROUND: Activity and safety of the SARS-CoV2 BNT162b2 vaccine in actively treated patients with solid tumors is currently unknown.

METHODS: We conducted a retrospective study of 326 patients with solid tumors treated with anti-cancer medications to determine the proportion of cancer patients with immunogenicity against SARS-CoV2, following two doses of the BNT162b2 vaccine. Control group was comprised of 164 vaccinated healthy adults. Anti-SARS-CoV-2 S IgG (Immunoglobulin G) antibodies (Abs) were measured, using level>50 AU/ml as cutoff for seropositivity. Adverse effects were collected using a questionnaire. All statistical tests were 2-sided.

RESULTS: Most patients (205, 62.9%) were treated with chemotherapy, either alone or with additional therapy, 55 (16.9%) were treated with immune checkpoint inhibitors (ICI) and 38 (11.7%) with targeted therapy alone, 28 (8.6%) received other combinations. The vaccine was well tolerated and no severe side effects were reported. Among patients with cancer 39 (11.9%) were seronegative, compared to 5 (3.0%) of the control group (P=0.001). Median IgG titers were statistically significant lower among patients with cancer compared to control (931 AU/ml vs. 2817 AU/ml, P=0.003). Seronegativity proportions were higher in the chemotherapy treated group (19, 18.8%) compared to the ICI-treated patients (5, 9.1%) and to those treated with targeted therapy (1, 2.6%) (P=0.02. Titers were also statistically significant different among treatment types (P=0.002).

CONCLUSION: The BNT162b2 vaccine is safe and effective in actively treated patients with cancer. The relatively lower antibody titers and lower proportion of seropositive patients, especially among chemotherapy treated patients, call for continuing the use of personal protective measures in these patients, even following vaccination.

PMID:34453830 | DOI:10.1093/jnci/djab174

Eur Heart J Acute Cardiovasc Care. 2021 Aug 28:zuab074. doi: 10.1093/ehjacc/zuab074. Online ahead of print.

NO ABSTRACT

PMID:34453838 | DOI:10.1093/ehjacc/zuab074

Egypt J Immunol. 2021 Jul;28(3):138-144.

ABSTRACT

Asthma is a common chronic illness among school children, where different cytokines, including IL-8 play a role in its pathogenesis. IL-8 induces chemotaxis and migration of immune cells, especially neutrophils to the site of inflammation. IL-8 level was significantly increased in sputum of severely asthmatic patients, but can it be linked to some asthma phenotypes. Our aim of the study was to detect the IL 8 gene expression in different asthma phenotypes and to determine its relation to asthma severity. This case control study included 320 subjects (160 asthmatic and 160 matched controls) aged from 5 to 16 years old in Beni-Suef governorate. IL-8 gene expression was assessed by a real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and studied regarding its level in cases versus controls and its relations to severity, phenotype and other laboratory parameters. IL-8 gene expression was statistically higher in asthmatic cases (P<0.001) and was significantly correlated to the phenotype (presence of other allergy as urticaria and drug eruption) and degree of asthma symptoms (r=0.869, P<0.001), FEV1(r=0.757, P<0.001) and serum IgE level (r=0.789, P<0.001). IL-8 gene expression level is increased with the degree of severity in asthmatic children and can be looked for in certain asthma phenotypes especially in presence of other atopic manifestation.

PMID:34453785